Neutrophil-derived microvesicles influence adaptive immunity by acting as targeted messengers between innate and adaptive cells. These small membrane-bound particles carry proteins, lipids, and nucleic acids that can alter antigen presentation, cytokine environments, and lymphocyte responsiveness. As reviewed by Clotilde Théry Institut Curie, extracellular vesicles are capable of transferring functional cargo that reprograms recipient cells, a principle that applies to neutrophil microvesicles in immune contexts.
Mechanisms of modulation
Neutrophil microvesicles mediate antigen transfer and regulatory signaling. They can present or shuttle neutrophil-granule proteins and pathogen-derived peptides to antigen-presenting cells such as dendritic cells and macrophages, influencing subsequent T cell priming. They also deliver small RNAs and lipids that change gene expression in recipient cells; this miRNA delivery can dampen dendritic cell maturation and reduce T cell activation in some settings, while under other conditions microvesicle cargo promotes pro-inflammatory antigen presentation. Beat Gasser University of Bern has described how neutrophil-derived microparticles interact with mononuclear phagocytes to alter cytokine profiles, illustrating these bidirectional outcomes.
Relevance, causes and consequences
The impact of neutrophil microvesicles is context-dependent: during acute infection they may enhance adaptive clearance by delivering antigens and danger signals that boost T and B cell responses; during sterile inflammation or chronic disease they often carry anti-inflammatory mediators that limit tissue damage and promote resolution. Annexin A1 and other pro-resolving molecules identified in neutrophil particles can suppress excessive adaptive activation, a phenomenon explored in resolution biology by Mauro Perretti Queen Mary University of London. Consequences include modulation of vaccine efficacy, shaping of autoimmunity risk, and influence on chronic inflammatory diseases where persistent neutrophil activation skews adaptive responses.
Culturally and territorially, populations exposed to higher rates of pollution, smoking, or endemic infections may exhibit altered neutrophil activation and microvesicle profiles, with downstream effects on community-level susceptibility to autoimmune or infectious diseases. Environment-driven differences in neutrophil vesicle composition may therefore contribute to geographic variation in adaptive immune outcomes.
Understanding neutrophil-derived microvesicles offers translational opportunities: they are candidate biomarkers of immune status and potential therapeutic vectors to either enhance antigen-specific immunity or enforce tolerance. Continued mechanistic work linking vesicle cargo to adaptive-cell behaviour is essential to move from observation to clinical application.